A meta-analysis of vitamin K antagonists in the prevention of venous thromboembolism in major orthopedic surgery.

被引：0
|
作者：
Raskob, GE
Laporte, S
Zufferey, P
Cadroy, Y
Darmon, JY
Decousus, H
Mismetti, P
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA
[2] Univ Hosp, Clin Pharmacol Unit, Thrombosis Res Grp, St Etienne, France
[3] MediBridge Clin Res, Velizy Villacoublay, France
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1968
引用
收藏
页码：505A / 505A
页数：1
相关论文
共 50 条
  • [21] Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
    Antonijevic, Nebojsa
    Kanjuh, Vladimir
    Zivkovic, Ivana
    Jovanovic, Ljubica
    Vukcevic, Miodrag
    Apostolovic, Milan
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2020, 148 (9-10) : 613 - 620
  • [22] Statin use and the prevention of venous thromboembolism: a meta-analysis
    Agarwal, V.
    Phung, O. J.
    Tongbram, V.
    Bhardwaj, A.
    Coleman, C. I.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (10) : 1375 - 1383
  • [23] Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer, KA
    Eriksson, BI
    Lassen, MR
    Turpie, AGG
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (18): : 1305 - 1310
  • [24] Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism
    Moustafa, Fares
    Stehouwer, Alexander
    Kamphuisen, Pieter
    Carles Sahuquillo, Joan
    Samperiz, Angel
    Alfonso, Maria
    Pace, Federica
    Maria Surinach, Jose
    Blanco-Molina, Angeles
    Mismetti, Patrick
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2018, 171 : 74 - 80
  • [25] New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials
    Lorenzo Loffredo
    Ludovica Perri
    Maria Del Ben
    Francesco Angelico
    Francesco Violi
    Internal and Emergency Medicine, 2015, 10 : 499 - 506
  • [26] The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event -: A meta-analysis
    van Dongen, CJJ
    Hutten, BA
    Büller, HR
    Prins, MH
    ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (11) : 1285 - 1293
  • [27] Efficacy and safety of different durations of vitamin K antagonists therapies after venous thromboembolism: systematic review and network meta-analysis
    Wang, Wei
    Yan, Xue
    Li, Jue
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C233 - C233
  • [28] New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials
    Loffredo, Lorenzo
    Perri, Ludovica
    Del Ben, Maria
    Angelico, Francesco
    Violi, Francesco
    INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (04) : 499 - 506
  • [29] Effect on efficacy and safety of the timing of the first pentasaccharide (fondaparinux, Arixtra®) administration in the prevention of venous thromboembolism (VTE) after major orthopedic surgery.
    Turpie, AGG
    Bauer, KA
    Eriksson, BI
    Lassen, MR
    BLOOD, 2001, 98 (11) : 266A - 266A
  • [30] Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery. An observational study
    Samama, Meyer Michel
    Guinet, Celine
    Le Flem, Lena
    Ninin, Emmanuel
    Debue, Jean-Marc
    THROMBOSIS RESEARCH, 2012, 130 : S101 - S102
12345